Cita APA

Jing, W., Yan, W., Liu, Y., Li, J., Yu, J., & Zhu, H. (2019). Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. Cancer Biol Ther.

Citación estilo Chicago

Jing, Wang, Weiwei Yan, Yuguo Liu, Ji Li, Jinming Yu, y Hui Zhu. "Slight Advantages of Nimotuzumab Versus Cetuximab Plus Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma." Cancer Biol Ther 2019.

Cita MLA

Jing, Wang, et al. "Slight Advantages of Nimotuzumab Versus Cetuximab Plus Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma." Cancer Biol Ther 2019.